Skip to main content
. 2016 Dec 29;31(1):124–133. doi: 10.1111/jvim.14631

Table 2.

Comparison of demographic, clinical, and respiratory cytology findings at presentation in dogs with less severe bacterial pneumonia (BP) (requiring <2 days of hospitalization, n = 10) and more severe BP (requiring >2 days of hospitalization, n = 9, including 2 mortalities)

Dogs with <2 Days of Hospitalization Mean ± SD or Median (IQR) Dogs with >2 Days Hospitalization Mean ± SD or Median (IQR) P‐Value
Duration of hospitalization (days) 1.0 (0.5–1.1) 5.5 (3.3–5.8)
Age (years) 1.5 (0.8–5.6) 5.8 (2.6–7.6) .211
Sex Male 6/10
Female 4/10
Male 5/9
Female 4/9
Duration of clinical signs (days) 3.0 (1.0–7.0) 1.5 (1.0–3.5) .315
Body weight (kg) 36.5 ± 17.5 33.6 ± 24.6 .764
Body temperature (°C) 39.3 ± 0.9 39.6 ± 0.9 .419
Respiratory rate (breaths/min) 43 ± 22 61 ± 17 .064
Blood hematology (n = 19)
Leukocyte count (109/L) 20.2 ± 16.3 12.1 ± 6.5 .183
Segmented neutrophil count (109/L) 15.9 ± 14.2 9.3 ± 5.5 .234
Band neutrophil count (109/L) 0.1 (0.0–0.7) 1.4 (0.3–2.8) .035
Lymphocyte count (109/L) 2.2 ± 1.6 0.5 ± 0.3 .009
Eosinophil count (109/L) 0.4 ± 0.4 0.1 ± 0.2 .078
Monocyte count (109/L) 0.7 (0.4–2.3) 0.4 (0.2–1.4) .278
Basophil count (109/L) 0.0 (0.0–0.0) 0.0 (0.0–0.0) .720
Arterial blood gas analysis (n = 19)
Arterial Pao 2 (mmHg) 84.6 ± 6.8 69.0 ± 9.8 .001
Arterial Paco 2 (mmHg) 30.8 (27.0–31.1) 28.8 (28.4–32.2) .842
Alveolar–arterial O2 gradient 30.8 ± 10.8 46.5 ± 9.2 .003
pH 7.41 ± 0.02 7.41 ± 0.6 .893
HCO3 (mmol/L) 18.2 ± 1.7 18.7 ± 3.4 .669
Base excess (mEq/L) −4.6 ± 1.3 −4.3 ± 3.9 .833
Respiratory sample cytology (n = 15)
Neutrophils (%) 14.7 (5.3–76.2) 96.4 (46.8–97.8) .019
Eosinophils (%) 3.7 (0.6–13.2) 0.0 (0.0–0.4) .008
Mast cells (%) 0.0 (0.0–2.7) 0.0 (0.0–0.0) .254
Lymphocytes (%) 14.6 ± 11.2 2.3 ± 3.1 .008
Macrophages (%) 42.9 ± 22.9 17.2 ± 27.6 .077
Epithelial cells (%) 0.0 (0.0–0.2) 0.0 (0.0–8.5) 1.000

SD, standard deviation; IQR, interquartile range.

HHS Vulnerability Disclosure